Access cutting-edge lung cancer treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Detroit at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tolerability of immunotherapy-based combination therapy.
Sponsor: Gilead Sciences
Check if you qualify for this lung cancer clinical trial in Detroit, MI
If you're searching for lung cancer treatment options in Detroit, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.